Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another terrible quarter for the company, restructure of previous options price from $1.54 to a much lower price, adding further shares into POAI war chest to issue at later date.
These actions and conditions just reinforce my opinion of this company, unsuccessful, no leadership, etc. With New YEARLY LOWS coming shortly.
As I have repeated over and over again POAI is NOTHING but a rip-off company, their only goal is to make money for themselves and NOT their shareholders.
This company is only good for DILUTION of shares, multiple R/S and NOTHING more, for years to come if POAI is still in business which I doubt they will continue doing the same things.
They have NO real products nor a management that knows anything, they should be removed from the NASDAQ and put on the grey sheets where it belongs.
I bet the company doesn't have more than 50 shareholders if that, time to get out while you can.
No problem POAI could never go UP and stay UP, this company is the worst.
I am sure the company has less than 50 investors, AAPL offers their shareholders a 4 for 1 stock spilt, POAI offers their shareholders a 1 for 100.
Company is a total piece of C--P, it's only good as a tax loss.
My bad... I’m the one on the wrong stock. Sorry... just cash 400% with PRPO. Great day
Wrong stock bro... PRPO here
REMEMBER THAT POAI HAS ONCE AGAIN WON THE PRICE FOR BEING THE WORST STOCK COMPANY OF THE YEAR, HOPEFULLY, IT WILL CONTINUE TO REMAIN ON THE TOP NEXT YEAR AS WELL.
ANYONE INVESTING IN THIS COMPANY NEEDS TO HAVE THEIR HEAD EXAMINED, POAI KNOWS ONE THING AND THAT IS DILUTION, R/S AND MAKING MONEY FOR IRS CEO AND MANAGEMENT.
One of the worst if NOT the worst trading stock's on the board is POAI, the only person making money is the CEO who needs to make sure that his investment is secure by SELLING shares one way or the other to cover his loan to company.
This stock is totally controlled by Management, CEO and One or Two large shareholders in the company.
No investor in their right mind would BUY this turd, investing in POAI is like DEAD MONEY going nowhere but DOWN over time.
The upside for POAI is somewhere around $2.69, nothing to write home about for sure.
After all these years we are at $1.58, can't imagine why anyone would invest in POAI unless, they are looking for a tax loss.
There hasn't been a single news release from this company, that would offer a professional investor or analyst to be encouraged about.
Just one other question to ask and that is, has anyone here ever invested in a company's stock like POAI and had NEVER received any POSITIVE results.
Personally, I hope NOT as this company is by far the WORST investment anyone can invest in, best thing you can do is rid oneself of this nightmare.
Just fsorry for all those still hanging on to this C--P, POAI is by far the worst stock to be invested in as Markets make NEW HIGHS and this C--P keeps making NEW LOWS.
This company has by far the worst management, NOTHING it does is POSITIVE other than share dilution and R/S.
Bona. .. you don’t seem to have moved on at all .. it’s all stuck in your mind . ;)
Everyone I know including myself have DUMPED POAI and have moved on, NO one has any confidence that this company will ever be worth investing in.
As I have repeatedly said POAI is good for only 2 things, diluting company shares and offering R/S every year.
This company will NEVER see its stock price above $2.50-$2.75 in the next 3 years, and if does it will be the result of the usual R/S.
This is one of thre only stocks in the RED today, admit it POAI is the worst piece of c--p anyone could have invested in.
For year's on end this company can only do 2 things, Dilute their shares and R/S their stock when it gets BELOW $1.00.
Just a matter of time for that to happen again, time to get rid of the CEO and find new management that knows how to run a company.
Hope all POAI LONGS are bracing themselves for another week of LOWER prices as new yearly LOWS will be made.
As I have said repeatedly that POAI is good for only 2 things, share dilution and R/S.
This company will NEVER be successful or one to invest in their future.
I'm sure today will be another down day for p o a i, the only thing this company is good for is share dilution and reverse splits.
This company is nothing more than a scam, only ones making money are the CEO and his cronies.
No doubt this company is a total waiste, can't do anything right and has nothing that investors are willing to buy into.
I am sure that by 2022 POAI will still be $1.65, and don't forget that's with many more R/S and share dilution.
Time to DUMP this C--P and look for something more worth while, this is a loser and will always be one.
That's great, but what do they and yourself know that makes you both believe POAI really has something to invest in, haven't shown anything for years other than Stock Dilution and R/S.
It also seems that whenever the price rises on NEWS, it immediately drops right back to its original LOW, remains there until another release is made and then repeats the past.
Personally, I would love nothing more than to see POAI succeed as a company and in its share price, however, I really don't believe that is going to happen from past experience.
Armistice fund bought 550K shares
It's a rare stock that will never go very high, highest I can see this go is $2.65 if that.
POAI is best in doing 2 things, diluting its share structure and creating multiple R/S.
Honestly, this company has never, and will never prove itself to the professional investors market.
Bona .... Armistice hedge fund loaded at $1.44 and I loaded at $1.36 and I'm making money .. It's a rare Penny stock investment .
The only thing this company knows how to do is have reverse splits an offer more shares to dilute the pre-existing shares they already have, anyone investing this company what do you need a tax laws, no way an investor in this company will ever make money.
The only thing this company knows how to do is have reverse splits an offer more shares to dilute the pre-existing shares they already have, anyone investing this company what do you need a tax laws, no way an investor in this company will ever make money.
You just might be right, only time will tell.
However, from past history POAI usually never does what you think it's going to do.
Hopefully, this time will be different, and tomorrow we can see higher prices.
From today's pre-market indication, it appears as if POAI is back to its old ways a PUMP and then a DUMP.
Looks as if POAI will open LOWER as usual and then pull back to the $1.65-$1.75 area, evidently the news from yesterday after having been digested by investors and analysts didn't impress them at all.
It appears NOTHING that this company does ever turns out good, I am about to say goodbye to POAI real fast if things turn SOUTH and move on.
That’s a good point!! Always pump and dump on news... I really enjoyed the slow increase today, more stable. Behaved like a real stock and not penny stock. Hope it can keep that smooth uptrend.
That was from early this morning, now we need to actually see how important this really is for the company.
Many times in the past when POAI releases news, the share price immediately goes UP only to SELL-OFF the very next day.
Hopefully, this is NOT the case this time, and the company will finally be on the road to success.
Personally, I'm a little doubtful that this is the case, but, then again I could be wrong.
Predictive Oncology’s TumorGenesis Division Secures First Commercial Sale of its Novel Ovarian Cancer Cell Media
GlobeNewswire GlobeNewswire•June 18, 2020
A Top US Medical Institution Places the First Commercial Order for the Media used to grow Ovarian Cancer Cell Types that are Exceedingly Difficult to Grow and Retain the Signatures of the Patient Derived Sample.
MINNEAPOLIS, June 18, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI) (“Predictive” or “the Company”) a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, today announces that Predictive’s TumorGenesis division sold its first order of its unique ovarian cancer cell culture media for cancer cells collected from patient derived samples (PDx) through its distributor US Biological Corporation. The media used to grow the novel and unique ovarian cancer cell lines, licensed by TumorGenesis and its partner, GLG Pharma are able to retain 95%+ of the DNA and RNA as well as crucial proteomic signatures. The media was sold to a top rated medical university in the New England area for research in isolating and growing ovarian cancer cells from the fluid often found in the abdomen of women with advanced ovarian cancer, called the ‘ascites’ fluid. Ovarian cancer cell culturing from ascites fluids are notoriously difficult using standard media mixes often prone to failure and cell lines that are not representative of the patient’s ovarian cancer.
A recent publication highlighted the waste in research using unvalidated media and reagents that showed an increase from $28 billion in 20151 to 2020 experiments are the foundation of preclinical research and development, however, irreproducibility rates in preclinical experiments exceed 50%, costing the industry nearly $48 billion annually2.
“Capturing and culturing and then being able to study ovarian cancer cell types has always been limited by the ability to grow reproducible cultures that reflect what is in the patient”, said Richard Gabriel of TumorGenesis. “We now have isolated and grown 25 ovarian cancer cell types, 11 of that library, represents nearly 95% of all ovarian cancers, many of which have never been cultured prior to this time. This new media will allow researchers around the world to isolate and then culture ovarian cancer cell types and culture them reproducibly to find new targets for treatment, diagnostics or other studies on the close interrelationship of ovarian cancer tumor populations and how they are able to fool a patient’s immune system”, Mr. Gabriel highlighted.
Researchers around the world can now contact US Biological Corporation or Richard Gabriel at TumorGenesis for information on the new media(s) available - rgabriel@tumorgenesis.net.
About Predictive Oncology Inc.
Predictive Oncology (POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
TumorGenesis, Inc. a wholly owned subsidiary specializes in media’s that help cancer cells grow and retain their DNA/RNA and proteomic signatures providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. In addition, TumorGenesis is developing a ‘biomarker discovery’ kit and service for life science, pharmaceutical and biotech companies, and research institutions. Its products are sold on-line as well as through a global distributor; US Biologicals Corporation: http://www.usbio.net.
Soluble Biotech Inc., a division of Predictive Oncology Inc. has a technology that allows the company to screen proteins for both solubility and stability. The proteins that have been successfully improved by Soluble include vaccines, antibodies and other proteins used in disease treatment. The company can screen 12,000 possible combinations of formulations of any protein using an exceedingly small amount, 25 milligrams and uses a neural network (AI) and other programs to predict the best formulation combination. It confirms the formulations by making a soluble and stable protein solution. The team at Soluble has worked on other viruses and deadly bacteria to come up with formulations of target proteins that can be used to treat, diagnose, or identify specific protein targets for later drug design. Soluble is expanding its reach by offering its services to COVID-19 antibody and vaccine developers. By having a soluble and stable antibody or vaccine candidate at the highest concentration is not only important for final delivery but is also a critical component in pre-clinical testing in animal models as well as in in vitro assays. Over the last 7 years, Soluble has worked for many large pharmaceutical and biotech companies but has also helped smaller companies that mostly outsource their development to outside service companies. Along with the 4 operating machines, each capable of 12,000 screens per machine, it also sells individual kits for researchers whose budgets are constrained.
Soluble Biotech Inc. also specializes in removing, identifying, and isolating endotoxins from products that are used by researchers to culture cells and to help identify endotoxins that maybe hidden within a protective matrix. A notable example is its recent success in completion of a Phase 2 SBIR grant (July 2020 for final report) for the identification of endotoxins in patient samples that have HIV and are experiencing a syndrome known as ‘leaky gut’, where patients in its end result would succumb to septicemia. BioDtech’s detection of the endotoxin in the patient sample, alerts the clinician to start the appropriate therapy ahead of the presentation of the septicemia event. This test also works for patients with Crohn’s disease, ulcerative colitis disease or as a side effect of other drug treatments, such as chemotherapy and radiation. BioDtech’s products include a column of beads that extract endotoxins from samples as well as other kits to release bound endotoxins, improving their detection.
That would be nice should it happen, at the moment POAI appears to be in a slow but steady UPTREND.
Would be great to see $2.00 this week, then break above that resistance of $2.75 to really confirm breakout.
I'm encouraged by the way POAI has been trading these past few days, looks as if the trend is beginning to move HIGHER as if something positive is about to be released.
It would be wonderful to see the price break above $2.50, then go to $2.75 (a major price point), where it needs to HOLD and move HIGHER.
Should that occur, POAI is on its way to making NEW HIGHS, it's about time for that to happen!!!!
Going to be interesting to see how POAI trades this week, looking definitely for an upward move above $1.70-$1.75, should that NOT occur I'm SELLING out.
It has taken much too long for this company to have proven itself, I've waited long enough and this is the WEEK for Deliverance, at least for me.
Going to take a miracle for POAI to move UPWARD, I really don't know if the company has anything of importance that the market finds worthwhile.
Just because CEO and another individual bought stock, we don't really know what the circumstances were, and what additional perks they were given.
In the end only shareholders lose, NOT management remember that.
HOPE YOU ARE RIGHT, DOESN'T LOOK LIKE MUCH IS GOING ON FOR SOMETIME.
CEI Got 1.5M shares at $1.43 and became quiet since then .. and Armistice bought 540K .. You want to be in this .
That's if we ever get NEWS, company NEVER releases anything that matters, just FLUFF.
Heavy squeeze Ahead Once this gets news
The only way POAI will be able to gain in share price is to have another R/S, in that way we can at least see a price at maybe $2.50.
I am sure as many others here, have been waiting and waiting for something to happen with this company, and all the earlier company names it had over these years.
Unfortunately, the only thing we have to show is a company whose stock is trading at $1.50, would be nice to be surprised one of these years.
GOING TO BE VERY INTERESTING TO SEE IF POAI CAN BREAK ABOVE $1.60-$1.65 TODAY AND STAY THERE, WOULD BE EVEN BETTER SHOULD THAT HAPPEN AND THAT POAI CONTINUES MOVING HIGHER.
IF AND WHEN IT CAN GET TO AND ABOVE $3.00, I THEN BELIEVE THE COMPANY IS FINALLY ON THE WAY TO SUCCESS AND HIGHER PRICES ARE TO BE SEEN.
HERE'S HOPING FOR A GREEN DAY, AND MANY MORE TO COME!!!!!!
Just can't seem to break above $1.60 HOLD there and move HIGHER, hopefully that will happen by December 2020.
Must admit its alittle disappointing that investors don't seem to have any interest in this company, it releases numerous NEWS reports that seem to have absolutely NO effect on POAI's price.
POAI needs to close at these levels today, and continue moving HIGHER tomorrow with the same VOLUME.
Once POAI breaks above the $2.00 price, I believe eeveryone will be HAPPY since this could finally be the year for us believers.
Hedge fund loaded .. surprise bounce ahead ..
NO DOUBT POAI WILL BE DOWN EVEN IN THIS FANTASTIC MARKET TODAY, GETTING TO BELIEVE IT MIGHT BE BETTER TO SELL THIS STOCK AND MOVE ON.
Going to take a major positive announcement to get POAI moving, always SELLs OFF every time there is an UPWARD price movement, and returns to its LOWS.
THis company just can't seem to get its act together, releases NEWS reports that NEVER has any lasting importance, hopefully, one year shareholders will see $3.00 without a R/S as always.
MM swapping machine switched to bull side in afternoon .. this looks ready
Followers
|
108
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4378
|
Created
|
06/28/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |